Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1964 1
1966 1
1967 1
1973 1
1974 3
1975 2
1976 2
1977 6
1978 3
1979 3
1980 6
1981 4
1982 5
1983 2
1984 6
1985 17
1986 7
1987 12
1988 7
1989 14
1990 5
1991 11
1992 12
1993 16
1994 17
1995 21
1996 17
1997 8
1998 6
1999 8
2000 5
2001 6
2002 1
2003 1
2004 4
2005 4
2006 6
2007 7
2008 4
2009 3
2010 9
2011 7
2012 5
2013 2
2014 5
2015 6
2016 2
2017 2
2018 4
2019 3
2020 3
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

311 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM; DMD Care Considerations Working Group. Birnkrant DJ, et al. Among authors: bolen j. Lancet Neurol. 2018 Apr;17(4):347-361. doi: 10.1016/S1474-4422(18)30025-5. Epub 2018 Feb 3. Lancet Neurol. 2018. PMID: 29395990 Free PMC article. Review.
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.
Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S, Cullis CA, Doucette A, Garnsey JJ, Gaulin JL, Gershman RE, Lublinsky AR, McDonald A, Mizutani H, Narayanan U, Olhava EJ, Peluso S, Rezaei M, Sintchak MD, Talreja T, Thomas MP, Traore T, Vyskocil S, Weatherhead GS, Yu J, Zhang J, Dick LR, Claiborne CF, Rolfe M, Bolen JB, Langston SP. Soucy TA, et al. Among authors: bolen jb. Nature. 2009 Apr 9;458(7239):732-6. doi: 10.1038/nature07884. Nature. 2009. PMID: 19360080
A function for the lck proto-oncogene.
Bolen JB, Veillette A. Bolen JB, et al. Trends Biochem Sci. 1989 Oct;14(10):404-7. doi: 10.1016/0968-0004(89)90288-0. Trends Biochem Sci. 1989. PMID: 2683259 Review.
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.
Bouhaddou M, Lee RH, Li H, Bhola NE, O'Keefe RA, Naser M, Zhu TR, Nwachuku K, Duvvuri U, Olshen AB, Roy R, Hechmer A, Bolen J, Keysar SB, Jimeno A, Mills GB, Vandenberg S, Swaney DL, Johnson DE, Krogan NJ, Grandis JR. Bouhaddou M, et al. Among authors: bolen j. JCI Insight. 2021 Oct 22;6(20):e151982. doi: 10.1172/jci.insight.151982. JCI Insight. 2021. PMID: 34546978 Free PMC article.
311 results